Release Date: 11/02/21 08:34 Summary: Vita Group Market Update Price Sensitive: Yes Download Document 240.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%